Eti Yoles
Works at
Chief operating officer
Sources: reporter.nih.gov
Grants and prizes
R01, First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD), R01AG071810, 2021–2024, 1 Sept 2023
Sources: reporter.nih.gov